Paclitaxel Alternatives Compared
Paclitaxel | Enhertu | Letrozole |
|
---|
Paclitaxel | Enhertu (fam-trastuzumab deruxtecan) | Letrozole |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Breast Cancer - Adjuvant, Breast Cancer - Metastatic, Breast Cancer, Kaposi's Sarcoma, Nasopharyngeal Carcinoma, Non Small Cell Lung Cancer, Ovarian Cancer, Wilms' Tumor. paclitaxel... View more |
Prescription only
Prescribed for Breast Cancer - Metastatic, Solid Tumors, Breast Cancer, Non Small Cell Lung Cancer, Gastric Cancer. Enhertu may also be used for purposes not listed in this medication guide. |
Prescription only
Letrozole is a treatment that may be used to reduce the risk of breast cancer recurrence in postmenopausal women and also to increase the chance of ovulation in women with polycystic ovary syndrome... View more |
Related suggestions Breast Cancer
|
|||||||||||||||||||||||
More about Paclitaxel | More about Enhertu (fam-trastuzumab deruxtecan) | More about Letrozole | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Paclitaxel has an average rating of 7.2 out of 10 from a total of 10 ratings on Drugs.com. 44% of reviewers reported a positive effect, while 11% reported a negative effect. |
Enhertu has an average rating of 8.0 out of 10 from a total of 23 ratings on Drugs.com. 71% of reviewers reported a positive effect, while 5% reported a negative effect. |
Letrozole has an average rating of 6.5 out of 10 from a total of 358 ratings on Drugs.com. 49% of reviewers reported a positive effect, while 23% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: paclitaxel side effects in more detail. |
See also: Enhertu side effects in more detail. |
See also: letrozole side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
N/A |
Lower cost generic |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all paclitaxel prices |
View all Enhertu prices |
View all letrozole prices |
||||||||||||||||||||||||
Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
N/A |
Femara | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
17.4 hours |
136.8 hours |
48 hours |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 501 drugs are known to interact with paclitaxel:
|
A total of 170 drugs are known to interact with Enhertu:
|
A total of 112 drugs are known to interact with letrozole:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
N/A |
N/A |
July 25, 1997 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
|||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.